Abstract: An electrode for nonaqueous electrolyte secondary batteries, provided with a collector and a positive electrode active material layer arranged on the collector and contains a positive electrode active material. The positive electrode active material contains compound particles which have a layered structure composed of two or more transition metals, and which have an average particle diameter DSEM of from 1 ?m to 7 ?m (inclusive) based on the observation with an electron microscope, a ratio of the 50% particle diameter D50 in a volume-based cumulative particle size distribution to the average particle diameter DSEM, namely D50/DSEM of from 1 to 4 (inclusive), and a ratio of the 90% particle diameter D90 in the volume-based cumulative particle size distribution to the 10% particle diameter D10 in the volume-based cumulative particle size distribution, namely D90/D10 of 4 or less. The positive electrode active material layer has a void fraction of 10-45%.

Abstract: Provided is a toner comprising a toner particle comprising a binder resin and a. silica fine particle, wherein a total content of a polyvalent metal elements in the toner particle is 0.10 to 2.50 ?mol/g, a number-average particle diameter of a primary particle of the silica fine particle is 40 to 500 nm, and in the DD/MAS measurement of solid 29Si-NMR of the silica fine particle, peak PD1 corresponding to a silicon atom represented by Sia in a structure represented by formula (1) and peak PD2 corresponding to a silicon atom represented by Sib in a structure represented by formula (2) are observed, and when an area of the peak PD1 is defined as SD1 and an area of the peak PD2 is defined as SD2, SD1 and SD2 satisfy: 1.2?(SD1+SD2)/SD1?10.0.

Abstract: A semiconductor wafer includes pairs of semiconductor dies having test pads which are electrically coupled to each other to enable testing of pairs of semiconductor dies together at the same time. In this way, even wafers having large numbers of semiconductor dies can be tested with a semiconductor test assembly in a single touch-down test process.

Abstract: A semiconductor wafer includes pairs of semiconductor dies having test pads which are electrically coupled to each other to enable testing of pairs of semiconductor dies together at the same time. In this way, even wafers having large numbers of semiconductor dies can be tested with a semiconductor test assembly in a single touch-down test process.

Abstract: A semiconductor wafer includes pairs of semiconductor dies having test pads which are electrically coupled to each other to enable testing of pairs of semiconductor dies together at the same time. In this way, even wafers having large numbers of semiconductor dies can be tested with a semiconductor test assembly in a single touch-down test process.

Abstract: A medicament for preventive and/or therapeutic treatment of multiple sclerosis, especially a pain accompanying multiple sclerosis such as neuropathic pain, which contains a compound having a P2X4 receptor antagonist activity such as a compound represented by the general formula (IH), or a salt thereof or a hydrate or solvate thereof as an active ingredient.

Abstract: The toner contains binder resin-containing toner particles and silica fine particle S1, wherein the weight-average particle diameter of the toner is 4.0-15.0 ?m, both inclusive, peaks originating with the silica fine particle S1 are observed in 29 Si-NMR measurement of the silica fine particle S1, and, in the spectrum obtained by 29Si CP/MAS NMR or 29Si DD/MAS NMR, the peak area of a peak corresponding to the D1 unit structure in the silica fine particle S1, the peak area of a peak corresponding to the D2 unit structure in the silica fine particle S1, and the peak area of a peak corresponding to the Q unit structure in the silica fine particle S1 satisfy a prescribed relationship.

Abstract: A receipt processing device includes a determination unit, a digitization unit, and a transmission unit. The determination unit is configured to determine whether receipt data generated by a receipt generation unit is receipt data of a transaction receipt indicating contents of a commercial transaction or receipt data of a non-transaction receipt indicating contents of a non-commercial transaction. The digitization unit is configured to digitize, if the receipt data is receipt data of the transaction receipt, the receipt data with an addition of first classification information and digitize, if the receipt data is receipt data of the non-transaction receipt, the receipt data with an addition of second classification information different from the first classification information. The transmission unit is configured to transmit the receipt data digitized by the digitization unit to a server.

Abstract: A P2X4 receptor antagonist such as paroxetine, a diazepinedione derivative having the following formula (IX) is used as an agent for preventing or treating neuropathic pain associated with Guillain-Barré syndrome: wherein R1 is hydrogen, a C1-8 alkyl group, or the like; each R2 and R3 is hydrogen, a C1-8 alkyl group, or the like; each of R4 and R5 is hydrogen or the like; and W is a five-membered or six-membered heterocyclic ring optionally having one or more substituents and comprising one to four nitrogen atoms as the members of the ring.

Abstract: An automatic analyzer includes: a diluted sample holding unit configured to hold dilution containers into which a diluted sample is dispensed; a reaction container holding unit configured to hold reaction containers; a dispensing device configured to dispense the diluted sample from the dilution containers to the reaction containers; a measuring unit configured to perform optical measurement of the diluted sample reacted with reagents corresponding to test items in the reaction containers; a storage unit configured to store information on the diluted sample associated with each of the dilution containers; and a dispensing control unit. The dispensing control unit extracts a dilution container for collecting the diluted sample for retest by searching for the information on the diluted sample stored in the storage unit, and causes the dispensing device to perform a retest dispensing process.

Abstract: A manufacturing method for a conductive substrate, with which a conductive substrate including a substrate and a conductive thin wire arranged on the substrate are manufactured, includes in the following order, a step 1 of forming a thin wire containing a metal on the substrate; a step 2 of bringing the thin wire into contact with a solution containing an organic acid; and a step 3 of subjecting the thin wire to a plating treatment to form a conductive thin wire.

Abstract: A compound represented by the following General Formula (I), a tautomer or a stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof, is used as a voltage-dependent T-type calcium channel blocker: wherein A represents a 5-membered heteroaryl group or a fused ring of a 5-membered or 6-membered heterocyclic ring with a benzene ring or a pyridine ring, each of which may have a substituent; R represents a hydrogen atom or the like; B represents CR5(Q1) or NQ2, herein Q1 represents a benzimidazole group which may have a substituent, or the like; Q2 represents an alkyl group having 1 to 8 carbon atoms which may have a substituent, a heteroaryl group which may have a substituent, or the like; R0, R1, R2, R3, R4, and R5 each represent a hydrogen atom or the like; and n and m each represent 0, 1, or 2.

Abstract: To obtain an electromagnetic actuator capable of improving a thrust force of a movable element. Provided is an electromagnetic actuator, including: a stator, which has a first surface at one end in an axial direction and a second surface at another end in the axial direction, and is made of a soft magnetic material having a tubular space formed in the axial direction; and a movable element, which is disposed in the tubular space, and is configured to move along the axial direction, wherein the stator includes: a coil; a core portion; and a protrusion portion, wherein the movable element includes a movable element core made of a soft magnetic material and a permanent magnet, and wherein at least one of a radially inner side and a radially outer side of the permanent magnet is covered by a movable element core.

Abstract: A medicament for treating or preventing pruritus is provided. For the medicament for treating or preventing pruritus, a compound having a blocking action on Cav3.2T-type calcium channels represented by General Formulas (I) to (VI), a tautomer of the compound, a stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is used as an active ingredient.

Abstract: A compound represented by General Formula (I), a tautomer, a stereoisomer, or a pharmaceutically acceptable salt of the compound, or a solvate thereof is used as a voltage-dependent T-type calcium channel inhibitor, in the formula, A represents a benzene ring which may have a substituent or the like; B represents a hetero-fused ring consisting of a 5- or 6-membered heteroaryl ring having one to three same or different heteroatoms selected from an oxygen atom, a sulfur atom, and a nitrogen atom, and a carbon atom, as a ring-constituting atom, and a benzene ring, or the like, and the hetero-fused ring may have a substituent, and is bonded to a cyclopropyl group via a carbon atom constituting these rings; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like; R2 and R3 may be the same as or different from each other, and each represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like, or R2 and R3 together form CH2CH2 or the like; R4 represents a hydr

Abstract: A compound represented by General Formula (I), a tautomer, a stereoisomer, or a pharmaceutically acceptable salt of the compound, or a solvate thereof is used as a voltage-dependent T-type calcium channel inhibitor, in the formula, A represents a benzene ring which may have a substituent or the like; B represents a hetero-fused ring consisting of a 5- or 6-membered heteroaryl ring having one to three same or different heteroatoms selected from an oxygen atom, a sulfur atom, and a nitrogen atom, and a carbon atom, as a ring-constituting atom, and a benzene ring, or the like, and the hetero-fused ring may have a substituent, and is bonded to a cyclopropyl group via a carbon atom constituting these rings; R1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like; R2 and R3 may be the same as or different from each other, and each represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or the like, or R2 and R3 together form CH2CH2 or the like; R4 represents a hydr

Abstract: To infer dynamic control information on a controlled object. An inferring device includes one or more memories and one or more processors. The one or more processors are configured to: input at least data about a state of a controlled object and time-series control information for controlling the controlled object, into a network trained by machine learning; acquire predicted data about a future state of the controlled object controlled based on the time-series control information via the network into which the data about the state of the controlled object and the time-series control information have been input; and output new time-series control information for controlling the controlled object to bring the future state of the controlled object into a target state based on the predicted data acquired via the network.

Abstract: A permanent magnet synchronous machine includes a stator including a plurality of split core blocks that are continuously arranged in a rotation direction of a rotor. The plurality of split core blocks each includes: a permanent magnet; a pair of teeth arranged on both ends of the permanent magnet so as to sandwich the permanent magnet in the rotation direction; and connection teeth, which are provided on axial end portions of the pair of teeth sandwiching the permanent magnet, and are configured to connect the pair of teeth.

Abstract: An inference apparatus includes one or more memories; and one or more processors. The one or more processors configured to acquire a latent state from input data regarding a control target; acquire a future latent state from the latent state and control data; infer, from the future latent state, a time series of a task to be executed by the control target to be controlled based on the control data; calculate a loss between the time series of the task and data indicating a target state; and update the control data based on the loss.

Abstract: A medicament for preventive and/or therapeutic treatment of multiple sclerosis, especially a pain accompanying multiple sclerosis such as neuropathic pain, which contains a compound having a P2X4 receptor antagonist activity such as a compound represented by the general formula (IH), or a salt thereof, or a hydrate or solvate thereof as an active ingredient.